Patents by Inventor John Docherty

John Docherty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20260053894
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise tirzepatide. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: August 25, 2025
    Publication date: February 26, 2026
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20260041737
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: October 21, 2025
    Publication date: February 12, 2026
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20250387416
    Abstract: Disclosed herein are compositions and methods for treating diabetes. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels.
    Type: Application
    Filed: June 19, 2024
    Publication date: December 25, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20250352623
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: July 25, 2025
    Publication date: November 20, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating diabetes
    Patent number: 12472236
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Grant
    Filed: December 3, 2024
    Date of Patent: November 18, 2025
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating diabetes
    Patent number: 12397042
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Grant
    Filed: December 3, 2024
    Date of Patent: August 26, 2025
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20250177489
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20250177488
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20250177314
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
    Publication number: 20250161333
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: January 2, 2025
    Publication date: May 22, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 12220422
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: February 11, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 12213986
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: February 4, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
    Publication number: 20250032518
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: February 14, 2024
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
    Publication number: 20250032517
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: January 19, 2024
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING EPILEPSY
    Publication number: 20250032516
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • COMPOSITIONS AND METHODS FOR TREATING HYPERTENSION
    Publication number: 20240226033
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Application
    Filed: March 25, 2024
    Publication date: July 11, 2024
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 12023346
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: July 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 11986485
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: May 21, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating hypertension
    Patent number: 11980593
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: May 14, 2024
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Compositions and methods for treating epilepsy
    Patent number: 11944635
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: April 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka